University of Colorado School of Medicine, Barbara Davis Center, Aurora, CO 80045 USA.
Ther Deliv. 2020 Aug;11(8):507-519. doi: 10.4155/tde-2020-0055. Epub 2020 Jul 28.
Type 1 diabetes (T1D) is a medical condition that requires constant management, including monitoring of blood glucose levels and administration of insulin. Advancements in diabetes technology have offered methods to reduce the burden on people with T1D. Several hybrid closed-loop systems are commercially available or in clinical trials, each with unique features to improve care for patients with T1D. This article reviews the Omnipod 5 Automated Glucose Control System Powered by Horizon™ and the safety and efficacy data to support its use in the management of T1D.
1 型糖尿病（T1D）是一种需要持续管理的医疗状况，包括监测血糖水平和胰岛素给药。糖尿病技术的进步提供了减轻 T1D 患者负担的方法。几种混合闭环系统已经上市或正在临床试验中，每个系统都具有独特的功能，可以改善 T1D 患者的护理。本文回顾了由 Horizon 驱动的 Omnipod 5 自动化血糖控制系统及其安全性和有效性数据，以支持其在 T1D 管理中的使用。
